Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 781-792 , December 2009

Conditions and drugs interfering with thyroxine absorption

  • Llanyee Liwanpo, MD (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. VA Greater Los Angeles Healthcare System, Endocrinology 111D, 11301 Wilshire Blvd, Los Angeles, CA 90073, USA. Tel.: +1 310 478 3711x41362; Fax: +1 310 268 4879.
    • ,
  • Jerome M. Hershman, MD (Professor)

References 

  1. Benvenga S, Bartolone L, Squadrito S, et al. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5:249–253
  2. Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Annals of Internal Medicine. 1979;90:941–942
  3. Topliss DJ, Wright JA, Volpé R. Increased requirement for thyroid hormone after a jejunoileal bypass operation. Canadian Medical Association Journal. 1980;123:765–766
  4. Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. International Journal of Obesity. 1986;10:245–246
  5. Stone E, Leiter LA, Lambert JR, et al. L-thyroxine absorption in patients with short bowel. The Journal of Clinical Endocrinology and Metabolism. 1984;59:139–141
  6. Vanderschueren-Lodeweyckx M, Eggermont E, Cornette C, et al. Decreased serum thyroid hormone levels and increased TSH response to TRH in infants with celiac disease. Clinical Endocrinology (Oxford). 1977;6:361–367
  7. Csako G, McGriff NJ, Rotman-Pikielny P, et al. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders. Annals of Pharmacotherapy. 2001;35:1578–1583
  8. Hays MT. Absorption of oral thyroxine in man. The Journal of Clinical Endocrinology and Metabolism. 1968;28:749–756
  9. Read DG, Hays MT, Hershman JT. Absorption of oral thyroxine in hypothyroid and normal man. The Journal of Clinical Endocrinology and Metabolism. 1970;30:798–799
  10. Hasselström K, Siersbaek-Nielsen K, Lumholtz IB, et al. The bioavailability thyroxine and 3,5,3′-triiodothyronine in normal subjects and in hyper- and hypothyroid patients. Acta Endocrinologica (Copenh). 1985;110:483–486
  11. Greenstadt MA, Spencer CA, Lum SMC, et al. Non-isotopic method for determination of oral thyroxine absorption. In:  Gueriguian JL,  Bransome ED,  Outschoorn AS editor. Hormone drugs: proceedings of the FDA-USP workshop on drug and reference standards for insulins, somatropins, and thyroid-axis hormones. Rockville: United States Pharmacopeial Convention Inc; 1982;p. 534–539
  12. Nicoloff JT, Low JC, Dussault JH, et al. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. The Journal of Clinical Investigation. 1972;51:473–483
  13. Wenzel KW, Kirschsieper HE. Aspects of the absorption of oral L-thyroxine in normal man. Metabolism. 1977;26:1–8
  14. Liel Y, Harman-Boehm I, Shany S. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. The Journal of Clinical Endocrinology and Metabolism. 1996;81:857–859
  15. Chiu AC, Sherman SI. Effects of pharmacological fiber supplements on levothyroxine absorption. Thyroid. 1998;8:667–671
  16. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18:293–301
  17. D'Estève-Bonetti L, Bennet AP, Malet D, et al. Gluten-induced enteropathy (coeliac disease) revealed by resistance to treatment with levothyroxine and alfacalcidol in a sixty-eight-year-old patient: a case report. Thyroid. 2002;12:633–636
  18. Silva CM, Souza MV. Autoimmune hypothyroidism nonresponsive to high doses of levothyroxine and severe hypocalcemia. Arquivos Brasileiros de Endocrinologia e Metabologia. 2005;49:599–603
  19. Caputo M, Brizzolara R, Schiavo M, et al. Occurrence of overt celiac disease in the elderly following total thyroidectomy. Journal of Endocrinological Investigation. 2006;29:831–833
  20. McDermott JH, Coss A, Walsh CH. Celiac disease presenting as resistant hypothyroidism. Thyroid. 2005;15:386–388
  21. Muñoz-Torres M, Varsavsky M, Alonso G. Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid. 2006;16:1171–1173
  22. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. The New England Journal of Medicine. 2006;354:1787–1795
  23. Phillips WA, Schultz JR, Stafford WW. Effects of colestipol hydrochloride on drug absorption in the rat. I. Aspirin, L-thyroxine, phenobarbital, cortisone, and sulfadiazine. Journal of Pharmaceutical Sciences. 1974;63:1097–1101
  24. Northcutt RC, Stiel JN, Hollifield JW, et al. The influence of cholestyramine on thyroxine absorption. The Journal of the American Medical Association. 1969;208:1857–1861
  25. Weitzman SP, Ginsburg KC, Carlson HE. Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine. Thyroid. 2009;19:77–79
  26. Daiichi Sankyo, Inc. Welchol(r) prescribing information. Available from: www. Welchol.com/pdf/Welchol_PI.pdf.
  27. Campbell RC, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Annals of Internal Medicine. 1992;117:1010–1013
  28. Shakir KM, Chute JP, Aprill BS, et al. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. Southern Medical Journal. 1997;90:637–639
  29. Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of L-thyroxine. American Journal of Medicine. 1994;90:531–535
  30. Havrankova J, Lahaie R. Levothyroxine binding by sucralfate. Annals of Internal Medicine. 1992;117:445–446
  31. Campbell JA, Schmidt BA, Bantle JP. Sucralfate and the absorption of L-thyroxine. Annals of Internal Medicine. 1994;121:152
  32. Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Archives of Internal Medicine. 1992;152:183–184
  33. Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. American Journal of Medicine. 1994;97:363–365
  34. Mersebach H, Rasmussen AK, Kirkegaard L, et al. Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments. Pharmacology & Toxicology. 1999;84:107–109
  35. Schneyer CR. Calcium carbonate and reduction of levothyroxine efficacy. [Letter] The Journal of the American Medical Association. 1998;279:750
  36. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. The Journal of the American Medical Association. 2000;283:2822–2825
  37. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid. 2001;11:967–971
  38. Diskin CJ, Stokes TJ, Dansby LM, et al. Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement. International Urology and Nephrology. 2007;39:599–602
  39. John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease levothyroxine absorption. Thyroid. 2007;17:763–765
  40. Siraj ES, Gupta MK, Reddy SS. Raloxifene causing malabsorption of levothyroxine. Archives of Internal Medicine. 2003;163:1367–1370
  41. Garwood CL, Van Schepen KA, McDonough RP, et al. Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene. Pharmacotherapy. 2006;26:881–885
  42. Sachmechi I, Reich DM, Aninyei M, et al. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocrine Practice. 2007;13:345–349
  43. Dietrich JW, Gieselbrecht K, Holl RW, et al. Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy. Hormone and Metabolic Research. 2006;38:57–59
  44. Ananthakrishnan S, Braverman LE, Levin RM, et al. The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption. Thyroid. 2008;18:493–498
  45. Madhava K, Hartley A. Hypothyroidism in thyroid carcinoma follow-up: orlistat may inhibit the absorption of thyroxine. [Letter] Clinical Oncology (Royal College of Radiologists (Great Britain)). 2005;17:492

PII: S1521-690X(09)00076-1

doi: 10.1016/j.beem.2009.06.006

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 781-792 , December 2009

Article Tools

* Image Usage & Resolution